The results of this study, conducted by Joseph Maroon, MD, and Jeff Bost, PAC, at the University of Pittsburgh (PA) were presented today at the American Association of Neurological Surgeons' annual meeting in New Orleans, LA.
Adult patients with non-surgical neck or back pain under physician's care were asked to supplement with 1200 mg of omega-3 EFAs, of which 900 mg are EPA (eicosapentaenoic acid) and 200 mg are DHA (docosahexaenoic acid).
After supplementing for an average of 75 days, 60% of the respondents reported reduction in both overall pain and joint pain, and 59% discontinued taking prescription pain medications or non-steroidal anti-inflammatory drugs (NSAIDs).
In additional reported results, 80% of the subjects reported being satisfied with the improvement experienced from supplementing with omega 3's, and 88% reported that they would continue to take them. Virtually no side effects were reported, which is noteworthy in light of the recent voluntary withdrawals of two widely prescribed NSAIDs: Vioxx® (10/30/04) and Bextra®.
Dr. Maroon noted that they were gratified "to see such a high percentage of patients who were able to stop taking their prescription NSAIDs after starting the omega-3 EFAs. Patient satisfaction exceeded 80%”.